Pharmacotherapy supports people with opioid use disorder (OUD) on their path to recovery. Also known as Medication for Opioid Use Disorder (MOUD) or Medication Assisted Treatment (MAT), it involves prescribing an FDA-approved opioid partial-agonist medication such as buprenorphine(link is external) to decrease the cravings and the fear of withdrawal that drive opioid use. It is one of the most effective evidence-based treatments for OUD.

In this webinar, Holly Russell and Michele Lawrence of the UR Medicine Recovery Center of Excellence discuss telemedicine MOUD as a bridging strategy. They go through key questions involved in implementing a program, including:

• How do we build the bridge?
• How do we operate the bridge?
• What is the future we are bridging to?